Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus Interventions: Drug: semaglutide injection (HD1916); Drug: Ozempic Sponsors: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting

https://clinicaltrials.gov/study/NCT06161844

Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Research